NG
CVS icon

Novem Group’s CVS Health CVS Stock Holding History

Novem Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
10,322
-756
-7% -$67.5K 0.11% 171
2026
Q1 		$796K Sell
11,078
-1,768
-14% -$136K 0.09% 210
2025
Q4 		$1.02M Sell
12,846
-1,414
-10% -$111K 0.12% 168
2025
Q3 		$1.08M Buy
14,260
+2,266
+19% +$155K 0.13% 154
2025
Q2 		$827K Buy
11,994
+206
+2% +$13.5K 0.1% 193
2025
Q1 		$799K Sell
11,788
-734
-6% -$43.9K 0.11% 176
2024
Q4 		$562K Buy
+12,522
New +$702K 0.08% 219

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Novem Group's CVS Position: Q2 2026 in Review

Novem Group reduced its CVS Health (CVS) stake by 6.8% in Q2 2026, selling an estimated $67.5K and leaving 10,322 shares worth $1.07M. The position accounts for 0.11% of the portfolio, ranked #171.

Novem Group first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.08M in Q3 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Novem Group held 10,322 shares of CVS Health worth $1.07M as of Q2 2026.
  • Novem Group sold 756 CVS Health shares in Q2 2026, an estimated $67.5K.
  • CVS Health made up 0.11% of Novem Group's portfolio in Q2 2026, its #171 holding.
  • Novem Group first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's CVS Health position peaked at $1.08M in Q3 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.